CVS HEALTH Corp Long-Term Concentrated

CIK: 0000064803 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 10, 2023

Total Value ($000): $115,995 (100.0% shares, 0.0% debt)

Holdings (6)

HDV ISHARES CORE HIGH DIVIDEND ETF 56.1%

Value ($000) $65,102 Shares 624,536 Est. Cost $100.99 Unrealized —

VYM VANGUARD WHITEHALL FDS 19.9%

Value ($000) $23,031 Shares 212,832 Est. Cost $112.25 Unrealized —

SCHD SCHWAB STRATEGIC TR US DIV 19.3%

Value ($000) $22,436 Shares 297,006 Est. Cost $78.89 Unrealized —

— LUMIRADX LTD 4.2%

Value ($000) $4,817 Shares 5,352,106 Est. Cost $8.91 Unrealized —

HCAT HEALTH CATALYST INC 0.3%

Value ($000) $343 Shares 32,273 Est. Cost $45.57 Unrealized -78.8%

PRU PRUDENTIAL FINANCIAL INC 0.2%

Value ($000) $267 Shares 2,683 Est. Cost $88.87 Unrealized -2.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HDV	ISHARES CORE HIGH DIVIDEND ETF	624,536	$65,102	56.1%	$100.99	—	COM	46429B663
VYM	VANGUARD WHITEHALL FDS	212,832	$23,031	19.9%	$112.25	—	COM	921946406
SCHD	SCHWAB STRATEGIC TR US DIV	297,006	$22,436	19.3%	$78.89	—	COM	808524797
—	LUMIRADX LTD	5,352,106	$4,817	4.2%	$8.91	—	COM	G5709L117
HCAT	HEALTH CATALYST INC	32,273	$343	0.3%	$45.57	-78.8%	COM	42225T107
PRU	PRUDENTIAL FINANCIAL INC	2,683	$267	0.2%	$88.87	-2.4%	COM	744320102